Order Article Reprints

Martínez-Bosch N, Vilariño N, Alameda F, Mojal S, Arumí-Uria M, Carrato C, Aldecoa I, Ribalta T, Vidal N, Bellosillo B, et al. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells. 2023; 12(6):843. https://doi.org/10.3390/cells12060843

Martínez-Bosch, Neus, Noelia Vilariño, Francesc Alameda, Sergi Mojal, Montserrat Arumí-Uria, Cristina Carrato, Iban Aldecoa, Teresa Ribalta, Noemí Vidal, Beatriz Bellosillo, and et al. 2023. "Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker" Cells 12, no. 6: 843. https://doi.org/10.3390/cells12060843

Martínez-Bosch, N., Vilariño, N., Alameda, F., Mojal, S., Arumí-Uria, M., Carrato, C., Aldecoa, I., Ribalta, T., Vidal, N., Bellosillo, B., Menéndez, S., Del Barco, S., Gallego, O., Pineda, E., López-Martos, R., Hernández, A., Mesia, C., Esteve-Codina, A., de la Iglesia, N., ... Navarro, P. (2023). Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells, 12(6), 843. https://doi.org/10.3390/cells12060843